Learn more
Join Dexa

Unraveling Alzheimer's

Peter and Thomas discuss the different ways Alzheimer's disease can develop, including the metabolic and vascular pathways. They explore the impact of dyslipidemia and statins on vascular complications and the potential link to reducing Alzheimer's disease. The conversation sheds light on the complexities of the disease and challenges common assumptions.
  • In this clip

  • From this podcast

    The Peter Attia Drive Podcast avatar

    The Peter Attia Drive Podcast

    #23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain

  • Related Questions

    • What does research say about statins and Alzheimer's in the context of the episode Dr. Peter Attia on Mastering Longevity – Insights on Cancer Prevention, Heart Disease, and Aging and the clip Statins and Neurodegeneration?

    • What does research say about statins and Alzheimer's in relation to the episode Dr. Peter Attia on Mastering Longevity – Insights on Cancer Prevention, Heart Disease, and Aging and the clip Statins and Neurodegeneration?

    • What does research say about statins and Alzheimer's in the context of the episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and the clip Cholesterol Management Insights, as well as in the context of the episode Dr. Peter Attia on Mastering Longevity – Insights on Cancer Prevention, Heart Disease, and Aging and the clip Statins and Neurodegeneration?

Built by
Charlie AI
© 2024 DexaPressTermsPrivacySupport